Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04568382 · ClinicalTrials.gov registry record · NA

Diabetes Communication and Treatment Burden

A NA study of Diabetes Mellitus, Type 2 and Multiple Chronic Conditions, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT04568382 is a NA study of Diabetes Mellitus, Type 2 and Multiple Chronic Conditions that has completed, run by University of California, Davis. The registered enrollment target is 24 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04568382, a NA study of Diabetes Mellitus, Type 2 and Multiple Chronic Conditions, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The objective of this proposal is to pilot test two types of pre-visit planning, where clinical staff reviews charts and talks to patients before their doctors appointments, to reduce the burden of diabetes care on the patient without increasing the visit workload during busy primary care clinics.

Interventions

  • OTHER CI-PVP (context-informed pre-visit planning)
  • OTHER Standard PVP (pre-visit planning)

Study Locations (1)

California

  • University of California, Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2020-10-12
Est. Completion 2023-06-30
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT04568382

The ClinicalTrials.gov registry entry for NCT04568382 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which CI-PVP (context-informed pre-visit planning) is the first listed.

NCT04568382 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04568382 about?

NCT04568382 is a clinical study titled "Diabetes Communication and Treatment Burden". The objective of this proposal is to pilot test two types of pre-visit planning, where clinical staff reviews charts and talks to patients before their doctors appointments, to reduce the burden of diabetes care on the patient without increasing the visit workload during busy primary care clinics.

What is the current status of trial NCT04568382?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2020-10-12. Estimated completion is 2023-06-30.

What conditions does trial NCT04568382 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Multiple Chronic Conditions.

What interventions are being tested in trial NCT04568382?

The interventions under investigation include: CI-PVP (context-informed pre-visit planning) (OTHER), Standard PVP (pre-visit planning) (OTHER).

Who is sponsoring clinical trial NCT04568382?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04568382 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.